Clinical Trial Update: Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov update describes a Phase 1/2 study evaluating an immune checkpoint inhibitor in combination with intrathecal pemetrexed for leptomeningeal me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis

Drugs mentioned

• Immune checkpoint inhibitor (unspecified)
• pemetrexed intrathecal injection (pemetrexed)

Snippet

Sponsor: Guangzhou Medical University | Conditions: Leptomeningeal Metastasis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING